Lipid Management Guidelines from the Departments of Veteran Affairs and Defense: A Critique

2016 ◽  
Vol 129 (9) ◽  
pp. 906-912 ◽  
Author(s):  
Catherine S. Bennet ◽  
Chanukya R. Dahagam ◽  
Salim S. Virani ◽  
Seth S. Martin ◽  
Roger S. Blumenthal ◽  
...  
Keyword(s):  
Management Guidelines ◽  
Lipid Management ◽  
Veteran Affairs

scholarly journals Adherence to lipid management guidelines is associated with lower mortality and major adverse limb events in patients undergoing revascularization for chronic limb-threatening ischemia

2017 ◽  
Vol 66 (2) ◽  
pp. 572-578 ◽  
Author(s):  
Thomas F.X. O'Donnell ◽  
Sarah E. Deery ◽  
Jeremy D. Darling ◽  
Katie E. Shean ◽  
Murray A. Mittleman ◽  
...  
Keyword(s):  
Lower Mortality ◽  
Management Guidelines ◽  
Lipid Management

scholarly journals Adherence to Lipid Management Guidelines and Outcomes in Patients Undergoing Revascularization for Chronic Limb-Threatening Ischemia

2017 ◽  
Vol 65 (3) ◽  
pp. e2
Author(s):  
Thomas Fx O'Donnell ◽  
Sarah E. Deery ◽  
Jeremy D. Darling ◽  
Katie E. Shean ◽  
Murray A. Mittleman ◽  
...  
Keyword(s):  
Management Guidelines ◽  
Lipid Management

A comparative analysis of three widely used lipid management guidelines in the EPIC-Norfolk cohort

2012 ◽  
Vol 20 (1) ◽  
pp. 98-106 ◽  
Author(s):  
Ersen B Colkesen ◽  
Harald T Jørstad ◽  
Ron JG Peters ◽  
S Matthijs Boekholdt ◽  
Jan GP Tijssen ◽  
...  
Keyword(s):  
Comparative Analysis ◽  
Management Guidelines ◽  
Lipid Management

scholarly journals Current Management Guidelines on Hyperlipidemia: The Silent Killer

2021 ◽  
Vol 2021 ◽  
pp. 1-5
Author(s):  
Lilly Su ◽  
Rea Mittal ◽  
Devyani Ramgobin ◽  
Rahul Jain ◽  
Rohit Jain
Keyword(s):  
Risk Factors ◽  
Statin Therapy ◽  
Treatment Options ◽  
The United States ◽  
Atherosclerotic Disease ◽  
Modifiable Risk Factors ◽  
Management Guidelines ◽  
Lipid Management ◽  
Coronary Events ◽  
New Treatment

Given the high incidence of cardiovascular events in the United States, strict control of modifiable risk factors is important. Pharmacotherapy is helpful in maintaining control of modifiable risk factors such as elevated lipids or hypercholesterolemia. Hypercholesterolemia can lead to atherosclerotic disease which may increase the risk of acute coronary events. Statin therapy has long been a mainstay in the treatment of hypercholesterolemia, but while highly regarded, statin therapy also has side effects that may lead to patient noncompliance. Therefore, various medicines are being developed to manage hypercholesterolemia. This paper will discuss the role that lipids play in the pathophysiology of atherosclerotic disease, review the current lipid management guidelines, and discuss new treatment options that are alternatives to statin therapy.

Sign in / Sign up

Export Citation Format

Share Document